No medication is FDA-approved specifically for borderline personality disorder (BPD), but several types of psychiatric medications are widely prescribed off-label to manage specific symptoms like anger, impulsivity, mood swings, and emotional instability. The American Psychiatric Association’s current guidelines treat medication as a supporting player, not the lead: any drug prescribed for BPD should target a specific, measurable symptom, be used alongside psychotherapy, and be time-limited rather than open-ended.
That distinction matters. Medication for BPD isn’t meant to treat the disorder as a whole. It’s meant to take the edge off particular symptoms that make therapy and daily life harder.
Why Nothing Is Officially Approved
BPD is a complex condition involving unstable relationships, shifting self-image, intense emotions, and impulsive behavior. No single drug addresses all of these dimensions, which is partly why no pharmaceutical company has pursued and received FDA approval for a BPD-specific medication. Instead, doctors prescribe drugs originally developed for depression, psychosis, or seizure disorders because those medications happen to help with overlapping symptoms like mood instability or aggression.
This off-label approach is common in psychiatry and doesn’t mean the prescriptions are experimental. It means the evidence comes from clinical trials in BPD populations rather than from an FDA-reviewed approval process. The strength of that evidence varies by drug class.
Antipsychotics for Anger and Impulsivity
Second-generation antipsychotics are among the most studied medications for BPD symptoms. A meta-analysis of 11 randomized controlled trials with over 1,150 participants found that antipsychotics had a small effect on perceptual disturbances, mood swings, and overall functioning, and a small to moderate effect on anger. The drugs tested included aripiprazole, olanzapine, quetiapine, and ziprasidone.
Aripiprazole stands out in the research. A separate systematic review found it reduced anger, impulsivity, depression, and anxiety in people with BPD. These benefits were observed in trials lasting six months or less, so long-term data is limited. Common side effects of antipsychotics include weight gain, drowsiness, and metabolic changes like elevated blood sugar or cholesterol, which is one reason guidelines emphasize keeping medication use time-limited and regularly reviewed.
Mood Stabilizers for Emotional Instability
The emotional rollercoaster of BPD, where feelings shift rapidly and intensely, has led researchers to test mood stabilizers originally developed for epilepsy or bipolar disorder. The results are mixed but promising for specific symptoms.
Lamotrigine and topiramate both reduced anger and impulsivity compared to placebo in clinical trials. Topiramate also improved interpersonal problems, as did valproate. An open-label follow-up found that reductions in anger and aggression from lamotrigine and topiramate persisted 18 months after the original trial. However, researchers concluded that mood stabilizers can help with several individual symptoms of BPD but do not reduce the overall severity of the disorder. They chip away at pieces of the problem rather than resolving the whole picture.
Antidepressants Have a Narrower Role
SSRIs are frequently prescribed for BPD, partly because depression and BPD so often overlap. But their benefit for core BPD symptoms is more limited than many people assume. A randomized, placebo-controlled trial of 38 women with BPD found that the SSRI fluvoxamine produced a significant, long-lasting reduction in rapid mood shifts. Importantly, this effect occurred regardless of whether participants also had depression or PTSD, suggesting it was targeting something specific to BPD rather than just treating a co-occurring mood disorder.
The catch: fluvoxamine showed no benefit for impulsivity or aggression. That pattern is fairly consistent across SSRI research in BPD. These drugs may help with the emotional volatility component, but they leave other core symptoms largely untouched. If your primary struggles are impulsive behavior or intense anger, an antidepressant alone is unlikely to be enough.
Omega-3 Fatty Acids as a Supplement
One unexpected finding from BPD research involves fish oil. A double-blind, placebo-controlled pilot study gave 30 women with moderately severe BPD either 1 gram of EPA (a specific omega-3 fatty acid) or a placebo daily for eight weeks. The omega-3 group showed greater reductions in both aggression and depressive symptoms compared to placebo. The researchers described it as a potentially safe and effective treatment on its own for moderate BPD.
This is a small pilot study, not definitive proof, but omega-3 fatty acids were included alongside prescription medications in a broader systematic review that found them helpful for anger, anxiety, depression, and impulsivity when used for six months or less. The low side-effect profile makes them worth discussing with a prescriber, particularly for people cautious about psychiatric medication.
How Medication Fits Into the Bigger Picture
The APA’s guidelines are clear that medication should be adjunctive to psychotherapy, not a replacement. Therapies like dialectical behavior therapy (DBT) remain the primary treatment for BPD and have the strongest evidence for improving the disorder’s core features, including relationship instability and identity disturbance, areas where medication has shown little effect.
The guidelines also recommend a thorough review before starting any new medication. This includes looking at co-occurring conditions (depression, PTSD, anxiety disorders, and substance use are all common alongside BPD), previous therapy attempts, past medication trials, and what you’re currently taking. The goal is to avoid piling on drugs without a clear rationale.
Once a medication is started, the APA recommends a medication review at least every six months to assess whether it’s actually working on the targeted symptom and whether any prescriptions should be tapered or stopped. This is particularly important because people with BPD often end up on multiple medications over time, each added for a different symptom, without anyone stepping back to evaluate whether the combination still makes sense.
What to Realistically Expect
If you’re considering medication for BPD, the honest picture is this: the right drug can meaningfully reduce specific symptoms like anger outbursts, rapid mood shifts, or impulsive decisions. It will not resolve the disorder. Effect sizes in clinical trials range from small to moderate, meaning medication typically takes the intensity down a few notches rather than eliminating the symptom entirely.
The most effective approach, based on current evidence, combines targeted medication with structured psychotherapy. Medication lowers the emotional temperature enough that therapy can do its deeper work on patterns of thinking, relating, and coping. If you’re exploring this route, the most productive conversation with a prescriber starts with identifying your most disruptive symptom and matching a medication to that specific target, rather than asking for something to treat BPD broadly.